NPPES file of Aug 9, 2026

Melisa Mary Minassian, RPH

Pharmacist · Pasadena, CA

Melisa Mary Minassian, RPH is a pharmacist with a practice address in Pasadena, California, and NPI 1841902087, issued on Dec 20, 2022. Check the license (California 87277, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1841902087
Name
Melisa Mary Minassian
Credential
RPH
Primary taxonomy
Pharmacist 183500000X
License number
87277 CA
Self-reported in NPPES; status is on the state search
Practice location
55 E California Blvd, Pasadena, CA 91105
Phone
(626) 795-5956
Enumerated
Dec 20, 2022
Record last updated
Dec 20, 2022
Fax
(626) 795-4998
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 55 E California Blvd

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. David Cantor, MDSpecialist1689646713
  2. Jennifer Chang, M.D.Endocrinology, Diabetes & Metabolism Physician1568631091
  3. Kristin Chapman, MDPediatrics Physician1093787822
  4. John Easthope, MDCardiovascular Disease Physician1174580328
  5. Walter Edmiston, MDCardiovascular Disease Physician1407811128
  6. Gregory Giesler, MDCardiovascular Disease Physician1477518454

Verify Melisa Mary Minassian in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich California board licenses this profession
    Search for license 87277
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

Most of these Medicare Part D claims are vaccines, 100% of the cost of the top drugs

38 Medicare Part D claims for 38 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.

  1. Melisa Minassian38
  2. Specialty average119

Most prescribed

Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.

  1. Arexvy23 claims
  2. Abrysvo11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Melisa Mary Minassian among 32,533 pharmacist records in California

Melisa Mary Minassian, RPH is one of 32,533 pharmacist records with a practice address in California. 15% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2022, is newer than 84% of them.

  • NPI issued2022 · 84% of these records are older, 12% newer
  • In a Medicare fileYes · 15% of these records are
  • In the CMS Doctors and Clinicians fileNo · under 1% of these records are
  • Record last updated2022 · 76% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 183500000X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

180 pharmacist records list a practice address in Pasadena

They are 180 of the 10,525 NPPES records with a practice address in Pasadena, and 32,533 pharmacist records in California.

The 8 pharmacist records with the nearest ZIP codes

  1. Laura Bearden, PHARMDPasadena, CA 911051225486434
  2. James Chang, PHARMDPasadena, CA 911051043623358
  3. Jasmine Chen, PHARMD, RPHPasadena, CA 911051346597291
  4. Seong Hong, RPH, PH.D.Pasadena, CA 911051174706410
  5. Clint Hutchings, PHARMDPasadena, CA 911051366722563
  6. Dunia IsmailPasadena, CA 911051245584929
  7. Minah Kim, PHARM. D.Pasadena, CA 911051073744264
  8. Wanda Lewis, PHARM. D.Pasadena, CA 911051922306737

Common questions

What is Melisa Mary Minassian, RPH's NPI number?

Melisa Mary Minassian, RPH's National Provider Identifier (NPI) is 1841902087, issued on Dec 20, 2022. An NPI identifies a provider in billing; it is not a license.

Where is Melisa Mary Minassian, RPH located?

The NPPES record lists a practice address at 55 E California Blvd, Pasadena, CA, 91105. Phone: (626) 795-5956. Providers update this record themselves, so call before visiting.

How can I verify Melisa Mary Minassian, RPH's license?

NPPES lists California license number 87277, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.

How much does Melisa Mary Minassian, RPH prescribe under Medicare Part D?

In 2024, Melisa Mary Minassian, RPH had 38 Medicare Part D claims for 38 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.